Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.2B |
| Sales growthchange from the year before | +36.5% |
| Net marginshare of sales kept as profit | 38.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 68.7% |
| Return on equityprofit vs. shareholders' accounting value | 39.9% |
| Debt / equitydebt vs. shareholders' accounting value | 0.03 |
| Change in share countnegative = the company is buying back its shares | +8.9% |
2 insiders sold $1.3M (92% under pre-arranged plans) on the open market.
| Gries Robert JRDirector | Sold (plan)Aug 4 | 28,212 shat $20.44 · $577K |
| Gries Robert JRDirector | Sold (plan)Aug 3 | 28,212 shat $20.33 · $574K |
| Rohde Stephen LDirector | SoldJul 31 | 5,000 shat $20.00 · $100K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy